Q1 2024 Holdings
Filed 2024-05-14 | 60 holdings | $122.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $38.2M | 703,606 | 31.2% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $10.7M | 77,240 | 8.7% |
| Biodesix Inc | COM | 09075X108 | $7.4M | 5,193,336 | 6.1% |
| Elutia Inc(ELUT) | COM | 05479K106 | $5.2M | 1,655,184 | 4.3% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $4.6M | 250,400 | 3.8% |
| Ovintiv Inc(OVV) | COM | 69047Q102 | $4.4M | 84,200 | 3.6% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $4.2M | 169,574 | 3.4% |
| Quidelortho Corp | COM | 74838J101 | $3.1M | 65,203 | 2.6% |
| Silk Road Medical Inc | COM | 82710M100 | $2.9M | 158,094 | 2.4% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $2.8M | 210,000 | 2.3% |
| Phreesia Inc(PHR) | COM | 71944F106 | $2.7M | 114,700 | 2.2% |
| United Therapeutics Corp(UTHR) | COM | 91307C102 | $2.5M | 11,000 | 2.1% |
| Masimo Corp(MASI) | COM | 574795100 | $2.2M | 15,280 | 1.8% |
| Foghorn Therapeutics Inc(FHTX) | COM | 344174107 | $2.2M | 320,930 | 1.8% |
| Harrow Health Inc(HROW) | COM | 415858109 | $2.0M | 150,000 | 1.6% |
| Docgo Inc(DCGO) | COM | 256086109 | $1.9M | 460,000 | 1.5% |
| Inhibrx Inc(INBXUSD) | COM | 45720L107 | $1.7M | 48,448 | 1.4% |
| Equitrans Midstream Corporatio(ETRNUSD) | COM | 294600101 | $1.7M | 133,050 | 1.4% |
| Axogen Inc(AXGN) | COM | 05463X106 | $1.4M | 173,000 | 1.1% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $1.4M | 48,000 | 1.1% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $1.4M | 50,000 | 1.1% |
| Corcept Therapeutics Inc(CORT) | COM | 218352102 | $1.3M | 50,000 | 1.0% |
| Alphatec Holdings Inc(ATEC) | COM | 02081G201 | $1.2M | 88,000 | 1.0% |
| 10X Genomics Inc(TXG) | CL A COM | 88025U109 | $1.1M | 30,000 | 0.9% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $1.1M | 18,000 | 0.9% |
| Pioneer Natural Resources Co(PXDEUR) | COM | 723787107 | $997.5K | 3,800 | 0.8% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $940.6K | 122,000 | 0.8% |
| Progyny Inc(PGNY) | COM | 74340E103 | $839.3K | 22,000 | 0.7% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $709.4K | 469,832 | 0.6% |
| Cytokinetics Inc(CYTK) | COM | 23282W605 | $701.1K | 10,000 | 0.6% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $645.3K | 270,000 | 0.5% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $619.2K | 15,000 | 0.5% |
| Kiniksa Pharmaceuticals LTD | COM | G5269C101 | $591.9K | 30,000 | 0.5% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $545.6K | 46,000 | 0.4% |
| Springworks Therapeutics Inc | COM | 85205L107 | $492.2K | 10,000 | 0.4% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $463.4K | 7,000 | 0.4% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $430.5K | 10,000 | 0.4% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $427.9K | 25,114 | 0.3% |
| Bluebird BIO Inc | COM | 09609G100 | $411.1K | 321,200 | 0.3% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $406.8K | 10,000 | 0.3% |
| Biohaven Pharmaceutical Holding Co LTD(BHVN) | COM | G11196105 | $402.8K | 7,365 | 0.3% |
| G1 Therapeutics Inc(GTHXEUR) | COM | 3621LQ109 | $345.6K | 80,000 | 0.3% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $329.8K | 28,000 | 0.3% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $323.7K | 2,500 | 0.3% |
| Accelerate Diagnostics Inc | COM | 00430H102 | $322.0K | 325,239 | 0.3% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $319.2K | 4,000 | 0.3% |
| Castle Biosciences Inc(CSTL) | COM | 14843C105 | $310.1K | 14,000 | 0.3% |
| Xencor Inc(XNCR) | COM | 98401F105 | $272.2K | 12,300 | 0.2% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $252.2K | 16,000 | 0.2% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $246.8K | 40,000 | 0.2% |